Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Saia Reports Fourth Quarter Results
-
Fingerprint Cards AB (Fingerprints) partners with leading advisory firm to grow IP commercialization and defend its technology
-
STAKING NOW AVAILABLE IN THE UK, UPHOLD RELAUNCHES SERVICE TO USERS
-
Outbrain Completes the Acquisition of Teads
-
HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial
-
IREN to Release Q2 FY25 Results on February 12, 2025
-
Allegro MicroSystems Appoints Dr. Krishna Palepu to its Board of Directors
-
uniQure Announces Completion of Enrollment in the First Cohort and Favorable Recommendation from the Independent Data Monitoring Committee for its Phase I/IIa Clinical Trial of AMT-191 for the Treatme
-
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
-
Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
-
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
-
Emerita’s 2024 Year in Review and Strategic Outlook for 2025
-
Brandywine Realty Trust and FS Investments Announce FS’s New Global Headquarters at Schuylkill Yards
-
Introducing HRCI ENGAGE, A Global Online Community for HR Professionals to Connect and Share Insights
-
Fury Commences 2025 Drilling Program at the Éléonore South Gold Project
-
Hemlo Explorers Announces Change in Management and Name Change to Rocky Shore Gold Ltd.
-
Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting
-
Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025
-
Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis
-
Brunswick Exploration Reports Phase 1 Metallurgical Results at Mirage with Potential for DMS-Only Flowsheet
-
FinLogic Quantitative Think Tank Center Led by Charles H. Sloan Innovates Investment Strategies
-
Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform
-
PyroGenesis’ Contract with Varennes Carbon Recycling Plant Project Increases to $3.6 million.
-
Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Bitfarms Provides January 2025 Production and Operations Update
-
LeddarTech Enters Into Amendments to Credit Facility and Bridge Financing Offer
-
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
-
Lavoro Reports Fiscal First Quarter 2025 Earnings Results
-
Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population
-
Village Farms International Commences Sales at Leli Holland Subsidiary in Netherlands
-
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscula
-
Zest Health Announces $13M in Funding to Curb Unnecessary Pharmaceutical Spend through High-Touch Care
-
Winnebago Industries, Inc. Announces Cash Tender Offer for 6.25% Senior Secured Notes Due 2028
-
OTC Markets Group Welcomes Digital Domain Holdings Limited to OTCQX
-
OTC Markets Group Welcomes Piraeus Financial Holdings to OTCQX
-
Alta Equipment Group Announces Common Stock Dividend
-
George Medicines appoints Amy Carroll as Senior Vice President of Medical Affairs
-
Evergen Launches AI-powered Bone Graft Image Processing Software Developed in Partnership with University of Florida
-
Liquidity Services Acquires Auction Software, a leading provider of auction software and marketplace technology
-
Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability
-
Brookfield Completes Acquisition of Chemelex
-
Genelux Corporation Announces New Chief Financial Officer
-
Brazil Potash Launches Archaeological Monitoring, Rescue Program, and Heritage Education for the Autazes Potash Project
-
Correction in dates: Disclosure of AS Tallinna Vesi's results in 2025
-
BioNTech Completes Acquisition of Biotheus
-
Nuvini Group Limited Reports Strong Growth in First Half 2024 Results
-
Net Asset Value(s)
-
Millionero Exchange Launches New Copy Trading Feature to Simplify Crypto Investing
-
Ocugen Announces Positive Opinion of European Medicines Agency’s Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for Modifier Gene Therapy Candidate OCU400 for
-
Elutia Announces $15.0 Million Registered Direct Offering
